Ionis Pharmaceuticals
Yahoo Finance • 14 days ago
Biogen Completes Acquisition of Alcyone Therapeutics
CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative CNS therapy delivery solutions, such a... Full story
Yahoo Finance • 14 days ago
Sanofi, Lilly among winners of EU drug recommendations this week
[Flag of European Union Waving Background] forest_strider/iStock via Getty Images During a meeting this week, an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed 10 new medicines for approval, including... Full story
Yahoo Finance • 14 days ago
Sector Update: Health Care Stocks Decline Premarket Friday
Health care stocks were declining premarket Friday, with the Health Care Select Sector SPDR Fund (XL PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 19 days ago
Biggest stock movers Monday: RUM, MTSR, and more
[financial disaster and crisis protection when market price fall.] Wongsakorn Napaeng/iStock via Getty Images Stock futures edged up Monday morning as reports surfaced that Senate negotiators reached a stopgap agreement to end the longest... Full story
Yahoo Finance • 20 days ago
Ionis Unveils Positive Phase 3 Data For Olezarsen In Severe Hypertriglyceridemia
(RTTNews) - Ionis Pharmaceuticals Inc. (IONS) announced positive results from its pivotal Phase 3 CORE and CORE2 studies evaluating olezarsen in patients with severe hypertriglyceridemia (sHTG). The trials successfully met their primary en... Full story
Yahoo Finance • 29 days ago
Alnylam Stock Has Almost Doubled In 2025. But It Took A Hit On Earnings.
Alnylam stock took a hit Thursday after the biotech company said it received a subpoena from the U.S. government related to its four drugs. Continue Reading View Comments... Full story
Yahoo Finance • 30 days ago
Ionis raises 2025 revenue guidance to $900M as TRYNGOLZA and DAWNZERA launches accelerate
Earnings Call Insights: Ionis Pharmaceuticals (IONS) Q3 2025 MANAGEMENT VIEW * Brett Monia, CEO, stated the third quarter was a “watershed moment for Ionis as we made important progress advancing first and best-in-class medicines for s... Full story
Yahoo Finance • last month
Ionis CEO Brett P. Monia receives 2025 Lifetime Achievement Award from the Oligonucleotide Therapeutics Society
CARLSBAD, Calif., October 21, 2025--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., Ionis’ chief executive officer, was awarded the 2025 Lifetime Achievement Award from the Oligonucle... Full story
Yahoo Finance • 2 months ago
Stocks making the biggest moves midday: TopBuild, Confluent, Alcoa, Viasat, Joby Aviation and others
Check out the companies making the biggest moves midday: TopBuild — The insulation installer rallied almost 8% after agreeing to buy Specialty Products and Insulation for $1 billion in cash . "The addition of SPI's resources and capabiliti... Full story
Yahoo Finance • 2 months ago
Ionis upgraded at JP Morgan on expanding Tryngolza market, pipeline
[Wall Street sign with American flag in the background, symbolizing the financial heart of New York.] JP Morgan upgraded Ionis Pharmaceuticals (NASDAQ:IONS [https://seekingalpha.com/symbol/IONS]) to overweight from neutral citing a potent... Full story
Yahoo Finance • 2 months ago
Intel, FedEx downgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Deutsche Bank upgraded Northrop Grumma... Full story
Yahoo Finance • 2 months ago
Stocks making the biggest moves premarket: AST SpaceMobile, Joby, Trilogy Metals, Rocket Lab and more
Check out the companies making headlines in premarket trading. Joby Aviation — Shares of the electric air taxi maker plunged 11% after the company announced the pricing of a previously announced stock offering. Joby will sell 30,500,000 co... Full story
Yahoo Finance • 2 months ago
Calumet, Inc. (CLMT): A Bull Case Theory
We came across a bullish thesis on Calumet, Inc. on The Pale Blue Dot’s Substack by Saad Khan. In this article, we will summarize the bulls’ thesis on CLMT. Calumet, Inc.'s share was trading at $18.66 as of September 22nd. CLMT’s trailing... Full story
Yahoo Finance • 2 months ago
CarMax downgraded, Kenvue upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Rothschild & Co Redburn upgraded Kenvue... Full story
Yahoo Finance • 2 months ago
Analysts See 11% Upside For JHML
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story
Yahoo Finance • 2 months ago
Ionis Pharmaceuticals Larger Than S&P 500 Component Align Technology
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Ionis Pharmaceuticals Inc (Symbol: IONS) was identified as having a larger market cap than the smaller end of the S&P 500, for example Align Tech... Full story
Yahoo Finance • 2 months ago
Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
CAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Company’s supplemental New Drug Application... Full story
Yahoo Finance • 2 months ago
Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates
Biogen to drive end-to-end development and commercialization of ThecaFlex DRx™, an investigational implantable device for intrathecal delivery of antisense oligonucleotides (ASOs)ThecaFlex DRx™ has the potential to be a new, convenient way... Full story
Yahoo Finance • 2 months ago
7 Biotech Stocks Trading At 52-Week Highs - Can The Rally Continue?
(RTTNews) - Patience is a virtue - important in all aspects of life, and especially crucial when it comes to investing. As trading expert Steve Burns once said, "Much of our trading comes down to a battle between our patience and our impul... Full story
Yahoo Finance • 3 months ago
Arrowhead sues Ionis over patent dispute related to lead asset
[Patent] JLGutierrez Arrowhead Pharmaceuticals (NASDAQ:ARWR [https://seekingalpha.com/symbol/ARWR]) sued Ionis Pharmaceuticals (NASDAQ:IONS [https://seekingalpha.com/symbol/IONS]) in a Delaware District Court on Wednesday as part of a pat... Full story
